Potential bias of preoperative intravitreal anti-VEGF injection for complications of proliferative diabetic retinopathy.

ABSTRACT:

Purpose

Intravitreal anti-VEGF injection (IVI) is administered before vitrectomy to assist management of proliferative diabetic retinopathy (PDR)-related complications. In the clinical setting, retinal surgeons determine the use of preoperative IVI based on individual criteria. In this study, we investigated factors related to the potential bias of retinal surgeons in using IVI prior to vitrectomy for PDR-related complications, and evaluated the real-world outcomes of surgeon-determined preoperative IVI.

Methods

Medical records of 409 eyes of 409 patients who underwent 25-gauge vitrectomy for PDR complications at seven Japanese centers (22 surgeons) were retrospectively reviewed. Ocular factors, demographic and general clinical factors, surgical procedures, and postoperative

SUBMITTER: Takayama K 

PROVIDER: S-EPMC8500446 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature